Arvind is planning to expand its textiles business to Rs. 10,000 crore by 2023, from Rs. 6,000 crore now. This will be achieved through verticalisation, more garmenting, ramping up advanced materials division which is into specialised textiles and adopting newer technologies.

Despite lull market conditions, the two open IPOs continued to received investor interest on Thursday, the second day of subscription. The Initial Public Offering (IPO) of state-owned railway engineering company RITES Limited and additive chemical major Fine Organics are open for subscription until Friday, June 22, 2018.

Following stocks are close to their 52-week low as at 12.52 p.m. on June 21, 2018.

The markets on June 21, 2018 opened up. BSE Sensex is trading at 35,526.86, down by 20.47 points and the Nifty is trading at 10,762.95, down by 9.10 points. 

Overall volumes in futures & options currently stand at 93.10 lakh contracts with a turnover of Rs. 8,87,651.18 crore.

In-line with the counter import duty hikes imposed by EU and China on goods originating from US, the Indian government has proposed to increase duty on apples, walnuts and non-alloy steel exported by the Americans.

Overall volumes in futures & options currently stand at 93.10 lakh contracts with a turnover of Rs. 8,87,651.18 crore.

In the coming session, support may come in at the levels of 10,700, followed by 10,650. On the upper side, the level of 10,820 is likely to act as an immediate resistance level for the Nifty. Stocks in news: InterGlobe Aviation, Mahindra Lifespace Developers, Adani Transmission, Gayatri Projects, JK Cement, Indiabulls Real Estate, Majesco and BHEL.

Key benchmarks are likely to witness a modestly positive opening following positive leads from Asian peers. The Nifty 50 index futures on the Singapore stock exchange are currently trading with modest gains of 14 points at 10,805.  

Multinational pharma company, Cipla posted a 3 per cent hike in its share price as the company received final approval for its new drug application (ANDA) for Efavirenz tablets 600mg from the United States Food and Drug Administration (USFDA).